Azmi Nabulsi's most recent trade in Phathom Pharmaceuticals Inc was a trade of 79,200 Common Stock done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 79,200 | 312,590 (1%) | 0% | 0 | Common Stock | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.59 per share. | 21 Jan 2025 | 7,886 | 233,390 (0%) | 0% | 6.6 | 51,957 | Common Stock |
| Phathom Pharma Inc | Nabulsi Azmi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 19 Dec 2024 | 1,118 | 239,303 (0%) | 0% | 8 | 8,944 | Common Stock |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 15 Jul 2024 | 10,901 | 240,421 (0%) | 0% | 11.7 | 127,760 | Common Stock |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 7,500 | 249,567 (1%) | 0% | 0 | Common Stoock | |
| Phathom Pharma Inc | Nabulsi Azmi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jul 2023 | 150,000 | 0 | - | - | Stock Option | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 110,000 | 209,567 (0%) | 0% | - | Common Stock | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jul 2023 | 70,000 | 0 | - | - | Stock Option | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 8.26 per share. | 11 Apr 2023 | 10,000 | 99,567 (0%) | 0% | 8.3 | 82,600 | Common Stock |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 45,000 | 89,567 (0%) | 0% | 0 | Common Stock | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 7,500 | 41,971 (0%) | 0% | 0 | Common Stock | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 12,000 | 33,378 (0%) | 0% | 0 | Common Stock | |
| Phathom Pharma Inc | Azmi Nabulsi | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 8.16 per share. | 16 May 2022 | 20,000 | 785,700 (3%) | 0% | 8.2 | 163,288 | Common Stock |